Letter: cytokeratin-18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization.
about
Letter: cytokeratin-18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Letter: cytokeratin-18 as a bi ...... ansarterial chemoembolization.
@en
Letter: cytokeratin-18 as a bi ...... ansarterial chemoembolization.
@nl
type
label
Letter: cytokeratin-18 as a bi ...... ansarterial chemoembolization.
@en
Letter: cytokeratin-18 as a bi ...... ansarterial chemoembolization.
@nl
prefLabel
Letter: cytokeratin-18 as a bi ...... ansarterial chemoembolization.
@en
Letter: cytokeratin-18 as a bi ...... ansarterial chemoembolization.
@nl
P2093
P2860
P356
P1476
Letter: cytokeratin-18 as a bi ...... ansarterial chemoembolization.
@en
P2093
P2860
P304
P356
10.1111/APT.13820
P407
P577
2017-01-01T00:00:00Z